LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 93 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $25,740,000 | -6.5% | 3,455,044 | -12.8% | 6.10% | -40.4% |
| Q4 2016 | $27,522,000 | +3.5% | 3,959,944 | +22.6% | 10.24% | +2.5% |
| Q3 2016 | $26,582,000 | +1.5% | 3,229,916 | -0.1% | 9.98% | -20.7% |
| Q2 2016 | $26,183,000 | +106.2% | 3,232,416 | +29.3% | 12.58% | +77.2% |
| Q1 2016 | $12,700,000 | -14.1% | 2,500,000 | +30.5% | 7.10% | +0.4% |
| Q4 2015 | $14,784,000 | +95.2% | 1,915,000 | +45.6% | 7.07% | +61.3% |
| Q3 2015 | $7,574,000 | -6.8% | 1,314,959 | +48.4% | 4.38% | -12.7% |
| Q2 2015 | $8,125,000 | +0.3% | 886,000 | +32.4% | 5.02% | -26.4% |
| Q1 2015 | $8,104,000 | – | 669,196 | – | 6.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |